We are international
Donate
TEXT SIZE   


John Gibson, M.D., Ph.D.
08.30.03
Royal Prince Alfred Hospital
Camperdown, NSW
Australia




Dr. Gibson is deputy director of the Institute of Haematology, head of the blood and marrow transplantation program, and a senior member of the Myeloma Research Group at Royal Prince Alfred Hospital in Sydney. He is also associate professor in medicine at the University of Sydney.

After graduating in medicine at the University of Sydney, Dr. Gibson worked at Sydney Hospital before commencing advanced training in hematology at Royal Prince Alfred Hospital. He gained fellowships of both the Royal Australasian College of Physicians as well as the Royal College of Pathologists of Australasia and subsequently a Ph.D. from the University of Sydney. Since 1986, he has been a senior member of the Institute of Haematology at RPAH. In 1995 he also spent some time as a visiting scientist at the Fred Hutchinson Cancer Research Centre in Seattle.

Dr. Gibson’s main research interests are myeloma, as well as the therapy of hematological malignancies in general, in particular the role of stem cell transplantation. He is a member of the joint myeloma subcommittee of the International Bone Marrow Transplantation Registry and Autologous Blood and Marrow Transplantation Registry and the representative of the Australian Leukaemia and Lymphoma Group on the International Myeloma Trialists’ Group. Non-myeloma interests include undergraduate and postgraduate teaching as well as patient education, having been a contributor to the IMF Patient & Family Seminars held in Australia.

The RPAH Myeloma Research Group has an active interest in the molecular genetics of myeloma as well as myeloma tumor immunology and the potential application of immune based therapies such as vaccination. In addition, active clinical research programs include the investigation of new approaches to primary therapy, reduced intensity allogeneic transplants, management of advanced disease and early detection of skeletal disease. It is one of the co-ordinating centres for the Australian Leukaemia and Lymphoma Group myeloma trials.

The RPAH Myeloma Research Group is also the proud host of the 10th International Myeloma Workshop, which will be held in Sydney in April 2005. Dr. Gibson is co-vice-president of the organising committee and a member of the national planning group for the scientific program.


 related articles